Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bidlingmaier

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Acta Paediatrica (Oslo, Norway : 1992). Supplement|December 24, 1997
Effects of growth hormone and insulin-like growth factor I binding to natural killer cellsM Bidlingmaier, C J Auernhammer, H Feldmeier, et al.
Hormone Research|October 31, 2001
Normal values of insulin-like growth factor I and their clinical utility in adultsC J Strasburger, M Bidlingmaier, Z Wu, et al.
Clinical Endocrinology|June 21, 2011
Effects on metabolic variables after 12-month treatment with a new once-a-week sustained-release recombinant growth hormone (GH: LB03002) in patients with GH deficiencyJ Roemmler, A Gockel, B Otto, et al.
European Journal of Endocrinology|January 10, 2009
Screening for membrane hormone receptor expression in primary aldosteronismO Zwermann, Y Suttmann, M Bidlingmaier, et al.
Cytokines, Cellular & Molecular Therapy|September 18, 1998
Cytokines and therapeutic oligonucleotidesG Hartmann, M Bidlingmaier, A Eigler, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 19, 2008
Serum leptin and ghrelin levels in active and inactive acromegalic patients during an oral glucose tolerance testJ Roemmler, B Otto, B Steffin, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 15, 2013
Novel use of endogenous GH-measurement directly after transsphenoidal microsurgery in acromegaly treated with pegvisomantD K Lüdecke, P A Crock, M Bidlingmaier, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|August 31, 2001
Findings and theoretical considerations on the usefulness of the acid-labile subunit in the monitoring of acromegalyK M Morrison, Z Wu, M Bidlingmaier, et al.
European Journal of Endocrinology|August 12, 2010
Influence of pegvisomant on serum ghrelin and leptin levels in acromegalic patientsJ Roemmler, B Otto, A M Arafat, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 5, 2002
Systemic regulation of distraction osteogenesis: a cascade of biochemical factorsS Weiss, R Baumgart, M Jochum, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Acta Paediatrica (Oslo, Norway : 1992). Supplement|December 24, 1997
Effects of growth hormone and insulin-like growth factor I binding to natural killer cellsM Bidlingmaier, C J Auernhammer, H Feldmeier, et al.
Hormone Research|October 31, 2001
Normal values of insulin-like growth factor I and their clinical utility in adultsC J Strasburger, M Bidlingmaier, Z Wu, et al.
Clinical Endocrinology|June 21, 2011
Effects on metabolic variables after 12-month treatment with a new once-a-week sustained-release recombinant growth hormone (GH: LB03002) in patients with GH deficiencyJ Roemmler, A Gockel, B Otto, et al.
European Journal of Endocrinology|January 10, 2009
Screening for membrane hormone receptor expression in primary aldosteronismO Zwermann, Y Suttmann, M Bidlingmaier, et al.
Cytokines, Cellular & Molecular Therapy|September 18, 1998
Cytokines and therapeutic oligonucleotidesG Hartmann, M Bidlingmaier, A Eigler, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 19, 2008
Serum leptin and ghrelin levels in active and inactive acromegalic patients during an oral glucose tolerance testJ Roemmler, B Otto, B Steffin, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 15, 2013
Novel use of endogenous GH-measurement directly after transsphenoidal microsurgery in acromegaly treated with pegvisomantD K Lüdecke, P A Crock, M Bidlingmaier, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|August 31, 2001
Findings and theoretical considerations on the usefulness of the acid-labile subunit in the monitoring of acromegalyK M Morrison, Z Wu, M Bidlingmaier, et al.
European Journal of Endocrinology|August 12, 2010
Influence of pegvisomant on serum ghrelin and leptin levels in acromegalic patientsJ Roemmler, B Otto, A M Arafat, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 5, 2002
Systemic regulation of distraction osteogenesis: a cascade of biochemical factorsS Weiss, R Baumgart, M Jochum, et al.
Pageof 9